References
- Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009;373:2055–66.
- Leverenz JB, Umar I, Wang Q, Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 2007;17:139–145.
- Spillantini MG, Schmidt ML, Lee VM, Alpha-synuclein in Lewy bodies. Nature 1997;388:839–40.
- Meulener M, Whitworth AJ, Armstrong-Gold CE, Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr Biol 2005;15:1572–77.
- Canet-Aviles RM, Wilson MA, Miller DW, The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 2004;101:9103–8.
- Bretaud S, Allen C, Ingham PW, Bandmann O. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J Neurochem 2007;100:1626–35.
- Cookson MR. DJ-1, PINK1, and their effects on mitochondrial pathways. Mov Disord 2010;25(Suppl 1):S44–8.
- Bonifati V, Rizzu P, van Baren MJ, Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256–59.
- Cookson MR. Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring Harb Perspect Med 2012;2(9):a009 415.
- Deeg S, Gralle M, Sroka K, BAG1 restores formation of functional DJ-1 L166P dimers and DJ-1 chaperone activity. J Cell Biol 2010;188:505–13.
- Wang Y, Lam KS, Yau MH, Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 2008;409:623–33.
- Yamauchi T, Kamon J, Minokoshi Y, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288–95.
- Nishimura M, Izumiya Y, Higuchi A, Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008;117:216–23.
- Jeon BT, Shin HJ, Kim JB, Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity. Brain Res Rev 2009;61:81–8.
- Jung TW, Lee JY, Shim WS, Adiponectin protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity. Biochem Pharmacol 2006;72(5):616–23.
- Song W, Huo T, Guo F, Globular adiponectin elicits neuroprotection by inhibiting NADPH oxidase-mediated oxidative damage in ischemic stroke. Neuroscience 2013;248C:136–44.
- Qiu G, Wan R, Hu J, Adiponectin protects rat hippocampal neurons against excitotoxicity. Age (Dordr) 2011;33(2):155–65.
- Cassani E, Cancello R, Cavanna F, Serum adiponectin levels in advanced-stage Parkinson's disease patients. Parkinsons Dis 2011:624764.
- Mao X, Kikani CK, Riojas RA, APPL1 binds to adiponectin receptors and mediates adiponectin signaling and function. Nat Cell Biol 2006;8(5):516–23.
- Deepa SS, Dong LQ. APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab 2009;296:E22–36.
- Ouchi N, Kihara S, Arita Y, Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000;102(11):1296–301.
- Chan KH, Lam KS, Cheng OY, Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicity. PLoS One 2012;7(12):e52354.
- Sheng B, Gong K, Niu Y, Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease. Free Radic Biol Med 2009;46(10):1362–75.
- Sheng B, Wang X, Su B, Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem 2012;120(3):419–29.
- He Y, Chang G, Zhan S, Soluble tissue factor has unique angiogenic activities that selectively promote migration and differentiation but not proliferation of endothelial cells. Biochem Biophys Res Commun 2008;370(3):489–94.
- Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond) 2008;32(Suppl 7):S13–8.
- Giaime E, Sunyach C, Druon C, Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6. Cell Death Differ Cell Death Differ 2010;17(1):158–69.
- Kumar H, Lim HW, More SV, The role of free radicals in the aging brain and Parkinson's disease: convergence and parallelism. Int J Mol Sci 2012;13(8):10478–504.
- Parker WD Jr., Parks JK, Swerdlow RH. Complex I deficiency in Parkinson's disease frontal cortex. Brain Res 2008; 1189:215–218.
- Bender A, Krishnan KJ, Morris CM High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006;38:515–17.
- Canet-Aviles RM, Wilson MA, Miller DW, The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 2004;101:9103–108.
- Irrcher I, Aleyasin H, Seifert EL, Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet 2010;19:3734–46.
- Wang X, Petrie TG, Liu Y, Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. J Neurochem 2012;121:830–39.
- Ren H, Fu K, Mu C, L166P mutant DJ-1 promotes cell death by dissociating Bax from mitochondrial Bcl-XL. Mol Neurodegener 2012;7:40.
- Vasseur S, Afzal S, Tardivel-Lacombe J, DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc Natl Acad Sci USA 2009;106:1111–6.
- McCullough LD, Zeng Z, Li H, Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 2005;280(21):20493–502.
- Martínez de Morentin PB, González CR, AMP-activated protein kinase: ‘a cup of tea’ against cholesterol-induced neurotoxicity. J Pathol 2010;222(4):329–34.
- Blázquez C, Geelen MJ, Velasco G, The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett 2001;489(2–3):149–53.
- Culmsee C, Monnig J, Kemp BE, AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 2001;17(1):45–58.
- Jung TW, Lee JY, Shim WS, Adiponectin protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Biochem Biophys Res Commun 2006;343(2):564–70.
- Nishimura M, Izumiya Y, Higuchi A, Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008;117: 216–23.
- Chen B, Liao WQ, Xu N, Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res 2009;1273:129–37.
- Sonmez FM, Zaman D, Aksoy A, The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy. Seizure 2013;pii:S1059-1311(13)00200-8.
- Osuka K, Watanabe Y, Yasuda M, Adiponectin activates endothelial nitric oxide synthase through AMPK signaling after subarachnoid hemorrhage. Neurosci Lett 2012;514(1):2–5.
- Lu DY, Chen JH, Tan TW, Resistin protects against 6-hydroxydopamine-induced cell death in dopaminergic-like MES23.5 cells. J Cell Physiol 2013 Mar;228(3):563–71.
- Ho PW, Liu HF, Ho JW, Mitochondrial uncoupling protein-2 (UCP2) mediates leptin protection against MPP+ toxicity in neuronal cells. Neurotox Res 2010;17(4):332–43.
- Giaime E, Sunyach C, Druon C, Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6. Cell Death Differ 2010;17:158–69.
- Qiu G, Wan R, Hu J, Adiponectin protects rat hippocampal neurons against excitotoxicity. Age (Dordr) 2011;33(2): 155–65.